Cynosure's Technology Showcased at the ASLMS Laser 2006 Conference
April 05 2006 - 9:00AM
PR Newswire (US)
Leading Dermatologists to Discuss Clinical Success with Company's
Products WESTFORD, Mass., April 5 /PRNewswire-FirstCall/ --
Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer
of a broad array of light-based aesthetic treatment systems, today
announced that industry-leading physicians and experts will discuss
the benefits of the company's technology in five presentations at
the American Society for Laser Medicine and Surgery (ASLMS) 26th
Annual Meeting, "Laser 2006." The meeting takes place today through
April 9 at the Sheraton Boston Hotel and Hynes Convention Center in
Boston. "These presentations showcase the strength of Cynosure's
expansive product line and our long-standing relationships with the
leading physicians in the industry," said Cynosure President and
Chief Executive Officer Michael Davin. "We continue to work closely
with these renowned experts to enhance our technologies so that
patients receive the highest quality treatments and doctors can
more efficiently build their practices." Cynosure's innovative
Cynergy with MultiPlex(TM) vascular laser system will be the focus
of the following three sessions on Friday, April 7 discussing the
advantages of using combined pulse dye laser and Nd:YAG lasers to
obtain superior treatment results: * Roy Geronemus, MD, Director of
the Laser & Skin Surgery Center of New York, and David J.
Goldberg, MD, J.D., Director of Skin Laser & Surgery
Specialists of NY/NJ, will present a pilot study titled
"Sequential, Dual Wavelength Treatment of Portwine Birthmarks." *
Emil A. Tanghetti, MD, Director of the Center of Dermatology and
Laser Surgery, will present "MultiPlex 595 nm, 1064 nm Laser
Treatment for Blebbed Portwine Birthmarks and Telangiectasia." *
Cynosure's Director of Clinical Studies Evan Sherr and Senior
Scientist Mirko Mirkov will present "Thermodynamic Remodeling of
Sequential, Dual Wavelength Treatment of Portwine Birthmarks."
Cynosure's state-of-the-art Affirm(TM) skin rejuvenation system,
which will be launched at Laser 2006, will be the focus of two
sessions on Saturday, April 8: * Robert A. Weiss, MD, and Margaret
A. Weiss, MD, of the Maryland Laser Skin & Vein Institute, will
present a study titled, "Comparison of Histological Features of
1550 nm Fractional Resurfacing and Micro-lens Array Scattering of
1440 nm." * Robert A. Weiss, MD, Margaret A. Weiss, MD, Natalie I.
Bene, MD, and Michael H. Gold, MD, will present results of a study
titled, "Prospective Clinical Trial of 1440 nm Laser Delivered by
Novel Micro- Array Lenses for Treatment of Scars and Rhytides,"
which discusses use of the Affirm system for scars and other
high-volume applications. With market opportunities for cellulite
treatment expanding, Dr. Gold, Founder and Director of Gold Skin
Care Center, will present a poster titled, "The Treatment of
Cellulite Utilizing a Medical Device Combining a Laser, Cooling and
Massage." Dr. Gold's poster describes favorable clinical findings
related to Cynosure's TriActive(TM) LaserDermology(SM) system.
About ASLMS The ASLMS was founded in 1980 to promote excellence in
patient care by advancing clinical application of lasers and
related technologies. Currently, the Society has over 3,000 members
and is a valuable resource for laser research, safety, education,
and clinical knowledge. For more information and referrals to laser
specialists, visit http://www.aslms.org/. About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems
that are used by physicians and other practitioners to perform
non-invasive procedures to remove hair, treat vascular lesions,
rejuvenate skin through the treatment of shallow vascular and
pigmented lesions and temporarily reduce the appearance of
cellulite. Cynosure's products include a broad range of laser and
other light-based energy sources, including Alexandrite, pulse-dye,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information, contact
Cynosure at 800-886-2966, or visit http://www.cynosurelaser.com/.
Contact: Timothy Baker 800-886-2966 DATASOURCE: Cynosure, Inc.
CONTACT: Timothy Baker of Cynosure, Inc., +1-800-886-2966, Web
site: http://www.cynosurelaser.com/ http://www.aslms.org/
Copyright
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Cynosure (NASDAQ:CYNO)
Historical Stock Chart
From Jul 2023 to Jul 2024